Basic Information
RNALocate ID: RLID:11002432
RNA Symbol: hsa-miR-362-5p
Localization: Exosome
RNA Information
RNA Name: hsa-miR-362-5p
RNA ID: miRBase:MIMAT0000705
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 25242326
Tissue/Cell Line: B cell lymphoma cell lines|EBV-transformed lymphoblastoid B cells
Method: Next-generation RNA sequencing
Description: Although the miRNA distribution in exosomal fractions is clearly influenced by cellular miRNA abundance, we identified a subset of miRNAs that were discordantly distributed between cells and exosomes (false discovery rate [FDR] < 0.05; Tables S1B and S1C).
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:01002017 Cytoplasm Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) 24918059
RLID:01002018 Mitochondrion Skeletal muscle myoblasts 21637849
RLID:01002019 Mitochondrion Cell line (HEK-293|HeLa) 22984580
RLID:01002020 Nucleus Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) 24918059
RLID:11002427 Exosome Serum 18589210
RLID:11002428 Exosome Primary dendritic cells|T cell line (J77) 21505438
RLID:11002429 Exosome Ovarian follicular fluid 22116803
RLID:11002430 Exosome Brain tissue 23382797
RLID:11002431 Exosome Plasma 23663360
RLID:11002433 Microvesicle Seminal plasma 23539611
RLID-D:11000407 Microvesicle Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells
RLID-D:11001191 Exosome Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-362-5p Multiple sclerosis chronic progressive MNDR-E-MI-43780
MNDR hsa-miR-362-5p Oral squamous cell carcinoma MNDR-E-MI-43781
MNDR hsa-miR-362-5p High-grade serous ovarian carcinoma MNDR-E-MI-43782
MNDR hsa-miR-362-5p Ovarian clear cell carcinoma MNDR-E-MI-43783
MNDR hsa-miR-362-5p Uterine corpus endometrial carcinoma MNDR-E-MI-43784
MNDR hsa-miR-362-5p Lymphoma MNDR-E-MI-43785
MNDR hsa-miR-362-5p Estrogen-receptor positive breast cancer MNDR-E-MI-43786
MNDR hsa-miR-362-5p Estrogen-receptor negative breast cancer MNDR-E-MI-43787
MNDR hsa-miR-362-5p Progesterone-receptor positive breast cancer MNDR-E-MI-43788
MNDR hsa-miR-362-5p Progesterone-receptor negative breast cancer MNDR-E-MI-43789
MNDR hsa-miR-362-5p Her2-receptor positive breast cancer MNDR-E-MI-43790
MNDR hsa-miR-362-5p Breast cancer luminal MNDR-E-MI-43791
MNDR hsa-miR-362-5p Neurofibromatosis 1 MNDR-E-MI-43792
MNDR hsa-miR-362-5p Dermatomyositis MNDR-E-MI-43793
MNDR hsa-miR-362-5p Prostate cancer MNDR-E-MI-43794
MNDR hsa-miR-362-5p Chronic lymphocytic leukemia MNDR-E-MI-43795
MNDR hsa-miR-362-5p Gastric cancer MNDR-E-MI-43796
MNDR hsa-miR-362-5p Alzheimer disease MNDR-E-MI-43797
MNDR hsa-miR-362-5p Intracranial aneurysm MNDR-E-MI-43798
MNDR hsa-miR-362-5p Esophageal carcinoma MNDR-E-MI-43799
MNDR hsa-miR-362-5p Dysautonomia familial MNDR-E-MI-43800
MNDR hsa-miR-362-5p Leukemia MNDR-E-MI-43801
MNDR hsa-miR-362-5p Down syndrome MNDR-E-MI-43802
MNDR hsa-miR-362-5p Parkinson disease MNDR-E-MI-43803
MNDR hsa-miR-362-5p Basal-like breast cancer MNDR-E-MI-43804
MNDR hsa-miR-362-5p Pancreatic cancer MNDR-E-MI-43805
MNDR hsa-miR-362-5p Melanoma MNDR-E-MI-43806
MNDR hsa-miR-362-5p Rectum adenocarcinoma MNDR-E-MI-43807
MNDR hsa-miR-362-5p Nephroblastoma MNDR-E-MI-43808
MNDR hsa-miR-362-5p Relapsing-remitting multiple sclerosis MNDR-E-MI-43809
MNDR hsa-miR-362-5p Ovarian cancer MNDR-E-MI-43810
MNDR hsa-miR-362-5p Prostate adenocarcinoma MNDR-E-MI-43811
MNDR hsa-miR-362-5p Invasive ductal carcinoma MNDR-E-MI-43812
MNDR hsa-miR-362-5p Glioblastoma MNDR-E-MI-43813
MNDR hsa-miR-362-5p Glioma MNDR-E-MI-43814
MNDR hsa-miR-362-5p Nemaline myopathy MNDR-E-MI-43815
MNDR hsa-miR-362-5p Amyotrophic lateral sclerosis MNDR-E-MI-43816
MNDR hsa-miR-362-5p Gastric adenocarcinoma MNDR-E-MI-43817
MNDR hsa-miR-362-5p Cervical squamous cell carcinoma MNDR-E-MI-43818
MNDR hsa-miR-362-5p Bone-invasive pituitary adenoma MNDR-E-MI-43819
MNDR hsa-miR-362-5p Lung squamous cell carcinoma MNDR-E-MI-43820
MNDR hsa-miR-362-5p Lung adenocarcinoma MNDR-E-MI-43821
MNDR hsa-miR-362-5p Adrenocortical cancer MNDR-E-MI-43822
MNDR hsa-miR-362-5p Thyroid carcinoma MNDR-E-MI-43823
MNDR hsa-miR-362-5p Ovarian carcinoma MNDR-E-MI-43824
MNDR hsa-miR-362-5p Myasthenia gravis autoimmune experimental MNDR-E-MI-43825
MNDR hsa-miR-362-5p Kidney renal clear cell carcinoma MNDR-E-MI-43826
MNDR hsa-miR-362-5p Kidney renal papillary cell carcinoma MNDR-E-MI-43827
MNDR hsa-miR-362-5p Clear cell renal cell carcinoma MNDR-E-MI-43828
MNDR hsa-miR-362-5p Cholangiocarcinoma MNDR-E-MI-43829
MNDR hsa-miR-362-5p Oncocytoma MNDR-E-MI-43830
MNDR hsa-miR-362-5p Lung small cell carcinoma MNDR-E-MI-43831
MNDR hsa-miR-362-5p Stomach carcinoma MNDR-E-MI-43832
MNDR hsa-miR-362-5p Hepatocellular carcinoma MNDR-E-MI-43833
MNDR hsa-miR-362-5p Neuroblastoma MNDR-E-MI-43834
MNDR hsa-miR-362-5p Hodgkin lymphoma MNDR-E-MI-43835
MNDR hsa-miR-362-5p Tonsil cancer MNDR-E-MI-43836
MNDR hsa-miR-362-5p Colorectal cancer MNDR-E-MI-43837
MNDR hsa-miR-362-5p Multiple myeloma MNDR-E-MI-43838
MNDR hsa-miR-362-5p Polymyositis MNDR-E-MI-43839
MNDR hsa-miR-362-5p Stroke lacunar MNDR-E-MI-43840
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter CYLD Homo sapiens RR00385272
TOP